Experimental
Introduction
Bioactive amines, catecholamines and indoleamines, play physiologically important roles in our body. Biological levels of these amines are related to various diseases, such as Parkinson disease, 1 hypertension, 2 neuroblastoma, 3 and pheochromocytoma, 3, 4 and are useful analytical tools in the diagnosis of these diseases.
Liquid chromatographic (LC) methods with native fluorescence detection, 5 electrochemical detection (ECD), 6 and mass spectrometry (MS) 7 have been used for the simultaneous determination of amines. However, the native fluorescence of catecholamines is very weak. Although the ECD method is sensitive, it tends to lack reproducibility, mainly due to hysteretic degradation of the electrode. The LC method with MS detection is sensitive and highly reliable, but its apparatus and operating cost are too expensive for routine analyses. On the other hand, fluorescence derivatization methods to convert weakly fluorescent compounds into strong fluorescent derivatives have been developed for the highly sensitive analysis of amines. 8, 9 However, the major defect of these methods in a highly sensitive assay is that other amino compounds are also derivatized to afford the same fluorescent spectra as those of catecholamines and indoleamines, which cause interfering peaks in the chromatogram. However, only a few selective fluorescent derivatization methods for catecholamines and indoleamines have been developed. [10] [11] [12] Thus, a simple and selective method for the simultaneous determination of catecholamines and indoleamines is needed.
We previously developed a selective determination method for tyrosine and tyramine through precolumn derivatization with a pyrene reagent and LC based on intramolecular excimerforming fluorescence derivatization. 13 The derivatization reagent, 4-(1-pyrene)butanoyl chloride (PBC), was shown to react with the primary amino moiety and the phenolic hydroxyl group of the amines by one-step derivatization. The resulting dipyrene-labeled derivatives provided intramolecular excimer fluorescence at the wavelength region of 440 -520 nm, which was shifted markedly to higher emission wavelengths, as compared to the wavelengths of the monopyrene-labeled monofunctional compounds (360 -420 nm). This chemistry allowed up to perform the selective analysis of tyrosine and tyramine, even in complex samples containing monoaminergic and monophenolic compounds, as is the cases with polyamine 14, 15 and bisphenol 16 analyses.
In the present paper, we describe an intramolecular excimerforming derivatization method for the fluorometric determination of bioactive amines, which have an amino moiety and a(two) phenolic hydroxyl group(s) in a molecule, based on the above-mentioned derivatization with PBC (Fig. 1) . The method allows a highly sensitive and selective determination of catecholamine-related compounds and indoleamines. Furthermore, this derivatization method was applied to the determination of bioactive amines in normal human urine. dissolved in acetonitrile was usable for at least 24 h when stored at -20˚C.
A Toyopak IC-SP S cartridge (Na + type, 0.15 mL) was purchased from Tosoh (Tokyo, Japan) and was rinsed with 3 mL of 2 M sodium phosphate buffer (pH 6.0) before use at a flow-rate of ca. 1 mL/min.
Pretreatment of urine sample
Urine samples were obtained from healthy volunteers (n = 7) in our laboratory. Aliquots of ca. 5 mL from single-morning samples were stored and frozen at -20˚C until being analyzed.
To a 500-μL aliquot of urine sample in a 1.5-mL polypropylene micro-tube, 500 μL of 1 M perchloric acid was added. After being vortex-mixed, the tube was centrifuged at 1000g for 15 min. To a 700-μL aliquot of supernatant, which was transferred to another micro-tube, 100 μL of 2 M potassium carbonate was added. After being vortex-mixed, the tube was centrifuged at 1000g for 5 min. The supernatant was applied onto the preconditioned Toyopak IC-SP S cartridge at a flowrate of ca. 1 mL/min. The cartridge was successively washed with 1.5 mL of water, 0.5 mL of 50% (v/v) methanol, and 5 mL of water; amine components were eluted with 500 μL of 1 M potassium chloride (ca. 1 mL/min). The eluate was diluted 50-fold with acetonitrile, and the obtained solution was subjected to derivatization.
Derivatization procedure
To a 200-μL aliquot of a standard solution or a pretreated urine sample placed in a 3.5-mL Reacti-vial (Pierce, Rockford, IL, USA), 5 μL of a 2 M potassium carbonate solution and 200 μL of a 5 mM PBC solution were added. The vial was tightly sealed and heated at 60˚C for 60 min. After cooling in icewater, 395 μL of 10 mM taurine was added to terminate the derivatization reaction and to decompose excess PBC. A 20-μL portion of the reaction mixture was injected into the chromatograph.
LC with fluorescence detection system
A gradient LC system consisting of a Jasco (Tokyo, Japan) PU-2085 liquid chromatograph pump, a Rheodyne (Cotati, CA, USA) Model 7725i syringe-loading sample injector equipped with a 20-μL sample loop, a Jasco DG-2085-53 on-line degasser, a Jasco LG-2085-03 low-pressure gradient unit, and a Waters (Milford, MA, USA) 2485 spectrofluorometer fitted with a 8-μL flow-cell was used. The pyrene-derivatives were separated on a reversed-phase TSKgel Super-ODS (100 × 4.6 mm i.d.; particle size, 2 μm; Tosoh) equipped with a guardcolumn (4.0 × 4.0 mm i.d.; Tosoh) by gradient elution with (A) acetonitrile-water-acetic acid (68:32:1, v/v) and (B) acetonitrile-water-acetic acid (90:10:1, v/v) as the mobile phases. Gradient elution began at 0% B, was kept constant at 0% for 8.0 min, was increased to 23% over 12 min, was increased to 100% over 20 min, was kept constant at 100% for 20 min, and was then reduced to 0% over 1 min. The total analysis time was 80 min. The flow-rate of the mobile phase was set at 1.0 mL/min, and the column temperature was ambient (23 ± 3˚C). The fluorescence detector was operated at excitation and emission wavelengths of 345 and 485 nm, respectively, and the slit-widths of both monochromators were set at 20 nm.
Results and Discussion

LC separation
We used catecholamines [3,4- with a free carboxylic group were co-eluted with the earlyeluting reagent blanks. They were moderately retained on a reversed-phase column using the acidic mobile phase by suppressing ionization of the carboxylic acid. In addition, we could not separate the PBC derivatives under isocratic elution because the polypyrene derivatives covered a broad range of hydrophobicity; some amines form respective dipyrene derivatives and the others tripyrene (described next section) and have a hydrophilic moiety (hydroxy or carboxyl), and the others not. Acceptable separations of the PBC derivatives of bioactive amines and reagent blank components (intermolecular excimer fluorescence peaks of PBC and its hydrolysate) were achieved on a TSKgel Super-ODS column using gradient elution from aqueous 68% acetonitrile to 90% in 60 min. A typical chromatogram obtained with a standard mixture of bioactive amines is illustrated in Fig. 2 
(A).
Derivatization conditions
Optimization studies for the derivatization were carried out to maximize the peak area of related amines. The optimum derivatization conditions were examined concerning the PBC concentration (0.1 -10.0 mM), water-miscible organic solvents (methanol, acetonitrile, N,N-dimethylformamide, dimethylsulfoxide, and 1,4-dioxane), potassium carbonate concentration (0.01 -6 M), reaction temperature (0 -100˚C), and time (1 -120 min).
The selected optimum conditions described in Experimental were almost similar to those of a previous method. 13 The pyrene-labeled bioactive amines in the final reaction mixture were stable, and still gave constant fluorescence intensities after left standing for at least 8 h in daylight at room temperature and for 3 days in the dark at 4˚C.
The structures of polypyrene derivatives were confirmed using LC-MS/MS according to a previous method. 13 The base peaks of the mass spectra for the peak components of DOPA and Tyr provided m/z values of 1007.6 and 720.7, respectively, which correspond to the quasi-molecular ion ([M-H] -) of tripyrene-labeled DOPA (M.W. 1008.2) and dipyrene-labeled Tyr (M.W. 721.8), respectively (data not shown). Thus, we guessed that all of the amino moiety and phenolic hydroxyl group(s) in catecholamines and indoleamines were derivatized with PBC under the present derivatization conditions. The proposed derivatization reactions with bioactive amines yielding the excimer-forming fluorescence derivatives are presented in Fig. 1 . Table 1 presents the analytical validation data. The relationships between the amounts of individual bioactive amines and the peak heights were linear over the concentration range of 10 nM -10 μM in the standard solution (50 fmol -50 pmol per 20 μL injection volume); the linear correlation coefficients were more than 0.994 (n = 3). The intra-and interday precision values were established by repeated determinations (n = 5) using a mixture of standard amines (1.0 μM each in a sample solution, 5 pmol each per 20 μL injection volume); the relative standard deviations of the intra-and interday precision were within 3.4 and 5.7%, respectively.
Analysis of standards
The detection limits (signal-to-noise ratio = 3) for bioactive amines were in the range of 4.5 -22 fmol per 20 μL injection volume, as can be seen in Table 1 . The sensitivities obtained by the present method were highly sensitive, and almost comparable to those of the most sensitive fluorescence derivatization methods.
Urine assay
In order to investigate the practicality of the intramolecular excimer-forming derivatization method in biological analysis, the present method was applied to the determination of catecholamine-related compounds and indoleamines in human urine. In our previous method, 13 Tyr and Tyra in urine could be determined without any pretreatments, owing to the selectivity of intramolecular excimer-forming fluorescence derivatization. [14] [15] [16] In this study, however, deproteinization with perchloric acid and solid-phase extraction were applied as a pretreatment of urine samples to obtain simpler chromatograms and to prevent any damage of the column. As shown in Table  2 , when we applied the pretreatment procedure described in 487 ANALYTICAL SCIENCES APRIL 2007, VOL. 23 Experimental, the recovery rates for all of the bioactive amines by addition (5 nmol/mL urine) were more than 79.2% with reasonable reproducibility; the calibration curves had satisfactory linearities (0 -5.0 nmol/mL urine). Figure 2 (B) illustrates a typical chromatogram obtained with a urine sample. The peak components of peaks 1 -11 in Fig. 2(B) were identified as PBC derivatives of corresponding bioactive amines, based on (a) their retention times compared with those of the standards and (b) co-elution of the standard and the sample using various gradient patterns. When a PBC solution in acetonitrile was replaced with only acetonitrile, no peaks were observed in the chromatogram. Furthermore, numerous biogenic compounds did not interfere with the determination of bioactive amines, because they could not emit at the excimer fluorescence region. 13 These observations support the idea that peaks 1 -11 in Fig. 2(B) have respective single components, the PBC derivatives of corresponding bioactive amines.
When different urine samples were assayed by the present method under various gradient patterns, no significant changes in the slopes of the added calibration graphs were observed. The determinable concentrations of urinary bioactive amines were lower than 0.51 nmol/mL urine (HTP) ( Table 2 ). The concentrations of bioactive amines in seven normal human urine samples (male, 5; female, 2) were determined by the proposed method. The concentrations of bioactive amines (nmol/mL; mean ± S.D.) in urine were as follows: HTP (0.68 ± 0.21), NMN (0.66 ± 0.28), Tyr (0.34 ± 0.12), Tyra (0.25 ± 0.10), HT (0.37 ± 0.13), MTyr (0.37 ± 0.11), MN (0.68 ± 0.28), DOPA (0.32 ± 0.05), DA (0.63 ± 0.16), NE (0.33 ± 0.08), and E (0.33 ± 0.06); those except Tyr are in good agreements with the reported data. [11] [12] [13] 17 
